Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/23/20
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 03/09/24
End: 09/30/29
Due: 09/30/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients | NCT04720326 | Edward Geissler | user2@example.com | None | 2020-12-23 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |
| Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs | NCT06268769 | Edward Geissler | user2@example.com | None | 2024-03-09 | 2029-09-30 | 2030-09-30 | - | - | 2025-07-14 |